BeOne Medicines Ltd.
Customers
2
2 active
Suppliers
1
1 active
Largest customer
18.5%
COR · FY to 2025-12-31
Named-customer revenue
$1.9B
2 customers · FY to 2025-12-31
Latest period
Dec 31, 2025
10-K filed 2026-02-26
Customers 2
Companies ONC discloses as major customers, as a share of ONC revenue. 2 active, 0 lapsed.
| Company | % of ONC revenue | Est. revenue | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| COR Distributor Cencora, Inc. |
18.5% | $988.5M | FY 2025-12-31 | +0.5pp | Active | 10-K 2026-02-26 |
For the year ended December 31, 2025, sales to the Company’s three largest product distributors, ASD Specialty Healthcare (Cencora), McKesson and Shanghai Pharmaceutical represented approximately 18.5%, 17.5% and 10.1% of product revenue, respectively, and collectively, represented approximately 37.1% of trade accounts receivable as of December 31, 2025. For the year ended December 31, 2024, sales to the Company’s three largest product distributors, ASD Specialty Healthcare (Cencora), McKesson and Shanghai Pharmaceutical represented approximately 18.0%, 16.9% and 11.1% of product revenue, respectively, and collectively, represented approximately 51.0% of trade accounts receivable as of December 31, 2024. | ||||||
| MCK Distributor MCKESSON CORP |
17.5% | $935.0M | FY 2025-12-31 | +0.6pp | Active | 10-K 2026-02-26 |
For the year ended December 31, 2025, sales to the Company’s three largest product distributors, ASD Specialty Healthcare (Cencora), McKesson and Shanghai Pharmaceutical represented approximately 18.5%, 17.5% and 10.1% of product revenue, respectively, and collectively, represented approximately 37.1% of trade accounts receivable as of December 31, 2025. For the year ended December 31, 2024, sales to the Company’s three largest product distributors, ASD Specialty Healthcare (Cencora), McKesson and Shanghai Pharmaceutical represented approximately 18.0%, 16.9% and 11.1% of product revenue, respectively, and collectively, represented approximately 51.0% of trade accounts receivable as of December 31, 2024. | ||||||
Suppliers 1
Companies that disclose ONC as a major customer, as a share of their own revenue. 1 active, 0 lapsed.
| Company | % of their revenue | Est. $ from ONC | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| AMGN AMGEN INC |
Named | — | FY 2025-12-31 | — | Active | 10-K 2026-02-26 |
As of December 31, 2025, the Company had purchase commitments amounting to $205,175, of which $24,921 related to non-utilization fees and minimum purchase requirements for supply purchased from contract manufacturing organizations and $180,254 related to binding purchase order obligations of inventory from Amgen. | ||||||
Alerts are coming
Get an email when ONC's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.